Increased energy expenditure and insulin sensitivity in the high bone mass ΔFosB transgenic mice

Endocrinology

Volumn 150, Issue 1, 2009, Pages 135-143

  Rowez, Glenn C ^a   Choi, Cheol Soo ^a   Neff, Lynn ^a   Home, William C ^a   Shulman, Gerald I ^a   Baron, Roland ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INSULIN; TRANSCRIPTION FACTOR DELTA FOSB;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; CELL SIZE; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY EXPENDITURE; FATTY ACID OXIDATION; INSULIN SENSITIVITY; LOCOMOTION; METABOLIC ACTIVATION; MOUSE; NONHUMAN; OBESITY; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BONE DENSITY; ENERGY INTAKE; ENERGY METABOLISM; FATTY ACIDS; INSULIN; MICE; MICE, TRANSGENIC; OBESITY; ORGAN SIZE; OSTEOCALCIN; PHOSPHOPYRUVATE HYDRATASE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 58149468066     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0678     Document Type: Article

References (45)

1. Karsenty G 2006 Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4:341-348
2. Rosen CJ, Bouxsein ML 2006 Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35-43
3. Chan GK, Duque G 2002 Age-related bone loss: old bone, new facts. Gerontology 48:62-71
4. Takeda S, Elefteriou F, Karsenty G 2003 Common endocrine control of body weight, reproduction, and bone mass. Annu Rev Nutr 23:403-411
5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig 5, Marshak DR 1999 Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
6. Reid IR 2002 Relationships among body mass, its components, and bone. Bone 31:547-555
7. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207
8. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R 2000 Overexpression of ΔFos B transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6:985-990
9. Jochum W, David JP, Elliott C, Wutz A, Plenk Jr H, Matsuo K, Wagner EF 2000 Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6:980-984
10. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ 2004 ΔFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 132:146-154
11. Wagner EF, Eferl R 2005 Fos/AP-1 proteins in bone and the immune system, Immunol Rev 208:126-140
12. Drissi H, Luc Q, Shakoori R, Chuva De Sousa Lopes S, Choi JY, Terry A, Hu M, Jones S, Neil JC, Lian JB, Stein JL, Van Wijnen AJ, Stein GS 2000 Tran-scriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol 184:341-350
13. Li AW, Morash B, Hollenberg AN, Ur E, Wilkinson M, Murphy PR 2001 Transcriptional regulation of the leptin gene promoter in rat GH3 pituitary and C6 glioma cells, Mol Cell Endocrinol 176:57-65
14. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K, Ohmichi M, Matsuzawa Y, Murata Y 2000 Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chern 275:11404-11411
15. Nakabeppu Y, Nathans D 1991 A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64:751-759
16. Yen J, Wisdom RM, Tratner I, Verma IM 1991 An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc Natl Acad Sci USA 88:5077-5081
17. Jooss KU, Funk M, Muller R 1994 An autonomous N-terminal trans activation domain in Fos protein plays a crucial role in transformation. EMBO J 13: 1467-1475
18. McClung CA, Nestler EJ 2003 Regulation of gene expression and cocaine reward by CREB and ΔFos B. Nat Neurosci 6:1208-1215
19. Sabatakos G, Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R, Philbrick WM, Baron R 2008 Doubly truncated FosB isoform (Δ2ΔFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. J Bone Miner Res 23:584-595
20. Kveiborg M, Sabatakos G, Chiusaroli R, Wu M, Philbrick WM, Home WC, Baron R 2004 ΔFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol Cell Biol 24:2820-2830
21. Kveiborg M, Chiusaroli R, Sims NA, Wu M, Sabatakos G, Home WC, Baron R 2002 The increased bone mass in ΔFosB transgenic mice is independent of circulating leptin levels. Endocrinology 143:4304-4309
22. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M, Reitman ML, Vinson C 1998 Life without white fat: a transgenic mouse. Genes Dev 12:3168-3181
23. Gundberg CM, Hauschka PV, Lian JB, Gallop PM 1984 Osteocalcin: isolation, characterization, and detection. Methods Enzymol 107:516-544
24. Gundberg CM, Nieman SD, Abrams S, Rosen H 1998 Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 83:3258-3266
25. Rosen ED, MacDougald OA 2006 Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7:885-896
26. Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, Lucas PC, Opp MR, MacDougald OA 2004 Wnt 10b inhibits development of white and brown adipose tissues. J Biol Chem 279:35503-35509
27. Chehab FF 2008 Obesity and lipodystrophy-where do the circles intersect? Endocrinology 149:925-934
28. Choi CS, Savage DB, Abu-Elheiga L, Liu ZX, Kim S, Kulkarni A, Distefano A, Hwang YJ, Reznick RM, Codella R, Zhang D, Cline GW, Wakil SJ, Shulman GI 2007 Continuous fat oxidation in acetyl-CoAcarboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA 104:16480-16485
29. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G 2007 Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469
30. Rosen ED, Spiegelman BM 2006 Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444:847-853
31. Rosen CJ 2008 Bone remodeling, energy metabolism, and the molecular clock. Cell Metab 7:7-10
32. Choi CS, Fillmore JJ, Kim JK, Liu ZX, Kim S, Collier EF, Kulkarni A, Distefano A, Hwang YJ, Kahn M, Chen Y, Yu C, Moore IK, Reznick RM, Higashimori T, Shulman GI 2007 Overexpression of uncouplingprotein 3 in skeletal muscle protects against fat-induced insulin resistance. J Clin Invest 117:1995-2003
33. Molero JC, Jensen TE, Withers PC, Couzens M, Herzog H, Thien CB, Langdon WY, Walder K, Murphy MA, Bowtell DD, James DE, Cooney GJ 2004 c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J Clin Invest 114:1326-1333
34. Molero JC, Turner N, Thien CB, Langdon WY, James DE, Cooney GJ 2006 Genetic ablation of the c-Cbl ubiquitin ligase domain results in increased energy expenditure and improved insulin action. Diabetes 55:3411-3417
35. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB 2002 Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343
36. Cha SH, Hu Z, Chohnan S, Lane MD 2005 Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proc Natl Acad Sci USA 102:14557-14562
37. Huypens P, Moens K, Heimberg H, Ling Z, Pipeleers D, Van de Casteele M 2005 Adiponectin-mediated stimulation of AMP-activated protein kinase (AMPK) in pancreatic β cells. Life Sci 77:1273-1282
38. Dobrzyn P, Dobrzyn A, Miyazaki M, Cohen P, Asilmaz E, Hardie DG, Friedman JM, Ntambi JM 2004 Stearoyl-Co A desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci USA 101:6409-6414
39. Trujillo ME, Scherer PE 2005 Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257: 167-175
40. Dyck DJ, Heigenhauser GJ, Bruce CR 2006 The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol(Oxf) 186:5-16
41. Santaniemi M, Kesaniemi YA, Ukkola O 2006 Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 155: 745-750
42. Ukkola O, Santaniemi M 2002 Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 80:696-702
43. Kelz MB, Chen J, Carlezon Jr WA, Whisler K, Gilden L, Beckmann AM, Steffen C, Zhang YJ, Marotti L, Self DW, Tkatch T, Baranauskas G, Surmeier DJ, Neve RL, Duman RS, Picciotto MR, Nestler EJ 1999 Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine. Nature 401:272-276
44. Olausson P, Jentsch JD, Tronson N, Neve RL, Nestler EJ, Taylor JR 2006 ΔFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J Neurosci 26:9196-9204
45. Brown JR, Ye H, Bronson RT, Dikkes P, Greenberg ME 1996 A defect in nurturing in mice lacking the immediate early gene fos B. Cell 86:297-309